This article is part of the supplement: Severe sepsis and drotrecogin alfa (activated)
Review
Clinical trials in severe sepsis with drotrecogin alfa (activated)
-
Correspondence: Pierre-François Laterre laterre@rean.ucl.ac.be
Critical Care 2007, 11(Suppl 5):S5 doi:10.1186/cc6156
No comments have yet been made on this article.